Charles Schwab Investment Management Inc Natera, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Natera, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,034,545 shares of NTRA stock, worth $112 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,034,545

Previous 997,909 3.67%

Holding current value

$112 Million

Previous $62.5 Million 51.37%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$59.21 - $92.9 $2.17 Million - $3.4 Million	36,636 Added 3.67%	1,034,545 $94.6 Million
Q4 2023 Feb 06, 2024	BUY	$37.55 - $62.64 $2.57 Million - $4.29 Million	68,480 Added 7.37%	997,909 $62.5 Million
Q3 2023 Nov 08, 2023	SELL	$43.4 - $62.52 $1.03 Million - $1.49 Million	-23,802 Reduced 2.5%	929,429 $41.1 Million
Q2 2023 Aug 09, 2023	BUY	$47.08 - $55.16 $2.23 Million - $2.61 Million	47,403 Added 5.23%	953,231 $46.4 Million
Q1 2023 May 11, 2023	SELL	$36.57 - $58.29 $106,382 - $169,565	-2,909 Reduced 0.32%	905,828 $50.3 Million

Q4 2022 Feb 13, 2023	BUY	$34.17 - $47.91 $4.19 Million - $5.87 Million	122,515 Added 15.58%	908,737 $36.5 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $2.95 Million - $4.53 Million	79,900 Added 11.31%	786,222 $34.5 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $232,241 - $367,722	8,256 Added 1.18%	706,322 $25 Million
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $593,271 - $1.79 Million	19,567 Added 2.88%	698,066 $28.4 Million
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $1.55 Million - $2.14 Million	17,976 Added 2.72%	678,499 $63.4 Million
Q3 2021 Nov 16, 2021	BUY	$100.17 - $126.36 $6.43 Million - $8.11 Million	64,220 Added 10.77%	660,523 $73.6 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $12.4 Million - $17.2 Million	-144,061 Reduced 19.46%	596,303 $67.7 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $4.59 Million - $6.24 Million	50,184 Added 7.27%	740,364 $75.2 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $1.68 Million - $2.81 Million	25,178 Added 3.79%	690,180 $68.7 Million
Q3 2020 Nov 13, 2020	BUY	$45.89 - $72.67 $9.1 Million - $14.4 Million	198,395 Added 42.52%	665,002 $48 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $1.73 Million - $3.26 Million	65,466 Added 16.32%	466,607 $23.3 Million
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $752,402 - $1.75 Million	-43,567 Reduced 9.8%	401,141 $12 Million
Q4 2019 Feb 07, 2020	BUY	$32.1 - $40.4 $3.08 Million - $3.88 Million	95,931 Added 27.5%	444,708 $15 Million
Q3 2019 Nov 08, 2019	BUY	$25.38 - $34.89 $320,016 - $439,928	12,609 Added 3.75%	348,777 $11.4 Million
Q2 2019 Aug 09, 2019	BUY	$17.75 - $27.58 $2.32 Million - $3.6 Million	130,666 Added 63.58%	336,168 $9.27 Million
Q1 2019 May 14, 2019	BUY	$11.34 - $20.62 $142,770 - $259,605	12,590 Added 6.53%	205,502 $4.24 Million
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $23,531 - $46,565	-1,910 Reduced 0.98%	192,912 $2.69 Million
Q3 2018 Nov 13, 2018	BUY	$18.82 - $28.96 $639,710 - $984,379	33,991 Added 21.13%	194,822 $4.67 Million
Q2 2018 Aug 08, 2018	SELL	$8.79 - $19.98 $102,728 - $233,506	-11,687 Reduced 6.77%	160,831 $3.03 Million
Q1 2018 May 07, 2018	BUY	$9.0 - $11.95 $162,459 - $215,709	18,051 Added 11.69%	172,518 $1.6 Million
Q4 2017 Jan 17, 2018	BUY	$8.99 - $14.31 $163,501 - $260,255	18,187 Added 13.35%	154,467 $1.39 Million
Q3 2017 Nov 13, 2017	BUY	$8.02 - $13.33 $1.09 Million - $1.82 Million	136,280	136,280 $1.76 Million

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Natera, Inc. Transaction History